Clinical question Recent 15-year updates of sigmoidoscopy screening trials triggered the clinical questions: Does colorectal cancer screening make an important difference to health outcomes in individuals initiating screening at age 50 to 79? Is there a preferable approach among the screening options faecal immunochemical test (FIT) every year or every two years, or a single sigmoidoscopy or colonoscopy
BACKGROUND: The long-term performance of colorectal cancer (CRC) screening programmes based on a 2-y...
BackgroundThe ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is ...
Background Preferences to choose immunochemical faecal occult blood test (FIT) and colonoscopy as co...
Recent 15-year updates of sigmoidoscopy screening trials provide new evidence on the effectiveness o...
CLINICAL QUESTION: Recent 15-year updates of sigmoidoscopy screening trials provide new evidence on...
CLINICAL QUESTION Recent 15-year updates of sigmoidoscopy screening trials provide new evidence o...
OBJECTIVE: To estimate benefits and harms of different colorectal cancer screening strategies, strat...
Background and aims: The comparative effectiveness of sigmoidoscopy and fecal immunochemical testing...
Since 1997, there has been a consensus that screening iseffective in reducing colorectal cancer mort...
Opinion statementColorectal cancer (CRC) imposes significant morbidity and mortality, yet it is also...
[[abstract]]The fecal immunochemical test (FIT) is underutilized, in part, because its benefits have...
[[abstract]]GOALS: To assess the association between the initial immunochemical fecal occult blood t...
Abundant evidence supports the concept of screening for colorectal cancer. The disease is of suffici...
__Abstract__ Colorectal cancer (CRC) is a major health concern. Approximately 1.2 million people ...
Background The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is...
BACKGROUND: The long-term performance of colorectal cancer (CRC) screening programmes based on a 2-y...
BackgroundThe ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is ...
Background Preferences to choose immunochemical faecal occult blood test (FIT) and colonoscopy as co...
Recent 15-year updates of sigmoidoscopy screening trials provide new evidence on the effectiveness o...
CLINICAL QUESTION: Recent 15-year updates of sigmoidoscopy screening trials provide new evidence on...
CLINICAL QUESTION Recent 15-year updates of sigmoidoscopy screening trials provide new evidence o...
OBJECTIVE: To estimate benefits and harms of different colorectal cancer screening strategies, strat...
Background and aims: The comparative effectiveness of sigmoidoscopy and fecal immunochemical testing...
Since 1997, there has been a consensus that screening iseffective in reducing colorectal cancer mort...
Opinion statementColorectal cancer (CRC) imposes significant morbidity and mortality, yet it is also...
[[abstract]]The fecal immunochemical test (FIT) is underutilized, in part, because its benefits have...
[[abstract]]GOALS: To assess the association between the initial immunochemical fecal occult blood t...
Abundant evidence supports the concept of screening for colorectal cancer. The disease is of suffici...
__Abstract__ Colorectal cancer (CRC) is a major health concern. Approximately 1.2 million people ...
Background The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is...
BACKGROUND: The long-term performance of colorectal cancer (CRC) screening programmes based on a 2-y...
BackgroundThe ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is ...
Background Preferences to choose immunochemical faecal occult blood test (FIT) and colonoscopy as co...